As we embark on a new year, our communication team has been working behind the scenes to bring you closer to the EFCCA community.

EFCCA is proud to partner in the innovative INTERCEPT IHI project, which aims to revolutionise the approach to Crohn’s dvisease by focusing on prevention and early intervention.

Register now to an exclusive webinar as part of the Horizon Europe Project FIBROTARGET. This engaging session will bring together leading experts and patient representatives to address the critical challenges posed by fibrosis in IBD.

Following the success of our HTA conference at UEGW last October, EFCCA is pleased to share the final report from a two-round consultation with stakeholders and experts.

We are excited to invite you to the upcoming EFCCA Conference "What do IBD patients find important in their treatment? -  Results from a global Patient
Preference survey” that will take place on 20 February 2025 at the ECCO Congress in Berlin.

This non-invasive technique is emerging as a valuable tool for diagnosis, treatment, and disease monitoring in IBD patients.

Aiming to revolutionise personalised prevention and early treatment in chronic inflammatory diseases (CIDs), the PerPrev-CID project focuses on advancing risk prediction, early detection of disease progression, and innovative preventive approaches in rheumatoid arthritis (RA) and Inflammatory Bowel Disease (IBD).

Registrations are open for the 1st GlycanTrigger Patients Symposium, an important event we are co-organising together with the Portuguese Society for Innovation (SPI), focused on collaborative discussions around strategies for predicting and preventing IBD.